Innate immune receptor genetic polymorphisms in pouchitis: Is CARD15 a susceptibility factor?

被引:64
作者
Meier, CB
Hegazi, RA
Aisenberg, J
Legnani, PE
Nilubol, N
Cobrin, GM
Duerr, RH
Gorfine, SR
Bauer, JJ
Sachar, DB
Plevy, SE
机构
[1] Univ Pittsburgh, Sch Med, Div Gastroenterol Hepatol & Nutr, Dept Med, Pittsburgh, PA 15261 USA
[2] Mt Sinai Med Ctr, Div Gastroenterol, Dept Med, New York, NY 10029 USA
[3] Mt Sinai Med Ctr, Dept Gen Surg, New York, NY 10029 USA
关键词
caspase activation and recruitment domain family member 15 gene; genetics; innate immunity; pouchitis; toll-like receptors;
D O I
10.1097/01.MIB.0000186407.25694.cf
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Pouchitis is a frequent complication after ileal pouch-anal anastamosis (IPAA) for ulcerative colitis (UC). The aim of this study was to determine whether genetic polymorphisms in the innate immune receptors toll-like receptor (TLR)4 and caspase activation and recruitment domain family member 15 (CARD15) genes are associated with pouchitis. Methods: From a retrospectively ascertained cohort of patients with UC 5 to 12 years after IPAA (n = 10 1), subjects were classified into 3 groups: no pouchitis (n = 52); 1 to 2 episodes per year (n = 11), and more than 2 episodes per year (n = 38). Single nucleotide polymorphisms in the tlr4 gene (D299G, T3991) were determined by a real-time polymerase chain reaction-based fluorogenic probe technique; and card15 polymorphisms (L1007fsinsC, R702W, G908R) were determined by pyrosequencing. Results: Pouchitis affected 49% (49/101) of the study population. No correlation between pouchitis and the presence of TLR4 polymorphisms was found. The percentage of patients who harbored CARD15 mutations was significantly higher in patients with pouchitis than in patients without pouchitis (18% versus 8%; P < 0.05); 24% of pouchitis patients with more than 2 episodes per year ilarbored CARD15 mutations (P < 0.01 compared with the no pouchitis group). The CARD15 insertion mutation L1007fsinsC was present in 14% of patients with pouchitis and in 0% without pouchitis (P < 0.05). All patients who carried L1007fsinsC developed more than 2 episodes per year. Conclusions: CARD15 polymorphisms are seen in greater frequency in patients with pouchitis after IPAA for UC. These findings, if borne out in prospective analyses, suggest that CARD15 mutations, particularly L1007fsinsC, may predispose to the development of pouchitis after IPAA for UC.
引用
收藏
页码:965 / 971
页数:7
相关论文
共 45 条
[21]   MUCOSAL CONCENTRATIONS OF INTERLEUKIN-1-BETA, INTERLEUKIN-6, INTERLEUKIN-BETA, AND TUMOR-NECROSIS-FACTOR-ALPHA IN PELVIC ILEAL POUCHES [J].
GIONCHETTI, P ;
CAMPIERI, M ;
BELLUZZI, A ;
BERTINELLI, E ;
BARBARA, L ;
FERRETTI, M ;
BRIGNOLA, C ;
POGGIOLI, G ;
MIGLIOLI, M .
DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (07) :1525-1531
[22]   Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation [J].
Holler, E ;
Rogler, G ;
Herfarth, H ;
Brenmoehl, J ;
Wild, PJ ;
Hahn, J ;
Eissner, G ;
Schölmerich, J ;
Andreesen, R .
BLOOD, 2004, 104 (03) :889-894
[23]   Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease [J].
Hugot, JP ;
Chamaillard, M ;
Zouali, H ;
Lesage, S ;
Cézard, JP ;
Belaiche, J ;
Almer, S ;
Tysk, C ;
O'Morain, CA ;
Gassull, M ;
Binder, V ;
Finkel, Y ;
Cortot, A ;
Modigliani, R ;
Laurent-Puig, P ;
Gower-Rousseau, C ;
Macry, J ;
Colombel, JF ;
Sahbatou, M ;
Thomas, G .
NATURE, 2001, 411 (6837) :599-603
[24]  
INOHARA N, 2004, ANNU REV BIOCHEM, P19
[25]   Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide [J].
Kirschning, CJ ;
Wesche, H ;
Ayres, TM ;
Rothe, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) :2091-2097
[26]   CARD15 Gene Mutations and Risk for Early Surgery in Pediatric-Onset Crohn's Disease [J].
Kugathasan, Subra ;
Collins, Nicole ;
Maresso, Karen ;
Hoffmann, Raymond G. ;
Stephens, Michael ;
Werlin, Steven L. ;
Rudolph, Colin ;
Broeckel, Ulrich .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (11) :1003-1009
[27]   Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-10 processing [J].
Maeda, S ;
Hsu, LC ;
Liu, HJ ;
Bankston, LA ;
Iimura, M ;
Kagnoff, MF ;
Eckmann, L ;
Karin, M .
SCIENCE, 2005, 307 (5710) :734-738
[28]   Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis [J].
Mimura, T ;
Rizzello, F ;
Helwig, U ;
Poggioli, G ;
Schreiber, S ;
Talbot, IC ;
Nicholls, RJ ;
Gionchetti, P ;
Campieri, M ;
Kamm, MA .
GUT, 2004, 53 (01) :108-114
[29]   Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease [J].
Mow, WS ;
Vasiliauskas, EA ;
Lin, YC ;
Fleshner, PR ;
Papadakis, KA ;
Taylor, KD ;
Landers, CJ ;
Abreu-Martin, MT ;
Rotter, JI ;
Yang, HY ;
Targan, SR .
GASTROENTEROLOGY, 2004, 126 (02) :414-424
[30]   A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease [J].
Ogura, Y ;
Bonen, DK ;
Inohara, N ;
Nicolae, DL ;
Chen, FF ;
Ramos, R ;
Britton, H ;
Moran, T ;
Karaliuskas, R ;
Duerr, RH ;
Achkar, JP ;
Brant, SR ;
Bayless, TM ;
Kirschner, BS ;
Hanauer, SB ;
Nuñez, G ;
Cho, JH .
NATURE, 2001, 411 (6837) :603-606